Search results for "Diabetes"
New diabetes drug, new indication for eosinophilic esophagitis
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/07/new-diabetes-drug-new-indication-for-eosinophilic-esophagitis.htm
1 Jul 2022
GLP-1 receptor agonists associated with thyroid cancer
Patients taking a glucagon-like peptide-1 (GLP-1) receptor agonist had about one and a half times the risk of developing thyroid cancer compared to similar controls, according to an observational French study.
https://immattersacp.org/weekly/archives/2022/11/22/2.htm
22 Nov 2022
Nonsugar sweeteners should not be used for weight loss, WHO guideline states
The World Health Organization (WHO) cited a lack of evidence suggesting that short-term use of nonsugar sweeteners affected body weight or other measures of adiposity, as well as possible long-term undesirable effects on noncommunicable diseases and death.
https://immattersacp.org/weekly/archives/2023/05/23/2.htm
23 May 2023
Sleep apnea, daytime sleepiness linked to higher coronary artery calcium scores
Patients with obstructive sleep apnea and daytime sleepiness had a 66% higher risk of atherosclerosis than those with neither condition, a Brazilian analysis found.
https://immattersacp.org/weekly/archives/2023/07/04/5.htm
4 Jul 2023
Statins associated with slightly higher diabetes risk
New report assesses health in every U.S. county
https://immattersacp.org/weekly/archives/2010/02/23/4.htm
23 Feb 2010
Subjects sought for study of chronic kidney disease in adult type 2 diabetes patients
The National Kidney Foundation is looking for primary care physicians and their patients to participate in a multi-site cross-sectional study to estimate the prevalence of chronic kidney disease in adult type 2 diabetes patients.
https://immattersacp.org/weekly/archives/2011/06/14/10.htm
14 Jun 2011
AI and IM, updates on weight loss drugs, and more
This issue includes cover stories on AI and GLP-1s for weight loss, as well as a feature on a new career development program and a preview of Internal Medicine Meeting 2024, among other stories.
https://immattersacp.org/archives/2024/03/ai-and-im-updates-on-weight-loss-drugs-and-more.htm
1 Mar 2024
ADA, EASD update guidance on managing hyperglycemia
An updated consensus statement from the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) addressed social drivers of health, lifestyle modifications, and new drug classes for type 2 diabetes.
https://immattersacp.org/weekly/archives/2022/10/04/1.htm
4 Oct 2022
Experts debate dilemmas in colorectal cancer screening
The latest ACP/Annals of Internal Medicine virtual forum discussed the controversy around colorectal cancer screening, clarified the rationale supporting the varying recommendations, and equipped physicians to make screening choices that best align with patients' clinical situations.
https://immattersacp.org/archives/2024/02/experts-debate-dilemmas-in-colorectal-cancer-screening.htm
1 Feb 2024
GLP-1 agonist plus basal insulin beat other diabetes treatment regimens in meta-analysis
Patients on combination treatment with a glucagon-like peptide-1 receptor (GLP-1) agonist and basal insulin had better HbA1c values, less weight gain, and similar hypoglycemia rates compared to patients on other type 2 diabetes treatment regimens, a new analysis of previous trials found.
https://immattersacp.org/weekly/archives/2014/09/23/2.htm
23 Sep 2014